ArticleJournal of comparative effectiveness research2023
Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma.
Noemi Muszbek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.